Rubius Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Rubius Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2022.
  • Rubius Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.82M, a 4.1% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $11.6M, a 57% increase from 2021.
  • Rubius Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $7.36M, a 13.2% decline from 2020.
  • Rubius Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $8.49M, a 57.9% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.82M -$78K -4.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $1.9M -$246K -11.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $2.15M +$1.97M +1113% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-20
Q1 2019 $177K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.